468 related articles for article (PubMed ID: 15727159)
1. [Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].
Knauf H; Mutschler E
Arzneimittelforschung; 2005; 55(1):1-14. PubMed ID: 15727159
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
Sjöström P
Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function.
Knauf H; Mutschler E
Eur J Clin Pharmacol; 1984; 26(4):513-20. PubMed ID: 6734710
[TBL] [Abstract][Full Text] [Related]
4. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
Rector WG
Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
[TBL] [Abstract][Full Text] [Related]
5. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
6. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
Alcázar Arroyo R
Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
[TBL] [Abstract][Full Text] [Related]
7. Clearance and micropuncture studies of the diuretic xipamide in dogs.
Strandhoy JW; Gomoll AW
Eur J Pharmacol; 1979 Feb; 54(1-2):173-6. PubMed ID: 421739
[TBL] [Abstract][Full Text] [Related]
8. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
9. Xipamide disposition in liver cirrhosis.
Knauf H; Gerok W; Mutschler E; Schölmerich J; Spahn H; Wietholtz H
Clin Pharmacol Ther; 1990 Dec; 48(6):628-32. PubMed ID: 2249374
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
[TBL] [Abstract][Full Text] [Related]
11. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
12. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
13. [Saluretic and diuretic effects of xipamide-triamterene combinations in varying dose ratios in rats].
Armah B; Dies R; Heinz N
Arzneimittelforschung; 1983; 33(1):131-5. PubMed ID: 6681965
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic and kinetic considerations on diuretics as a basis for differential therapy.
Knauf H; Mutschler E
Klin Wochenschr; 1991 Apr; 69(6):239-50. PubMed ID: 2038173
[TBL] [Abstract][Full Text] [Related]
15. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
16. Site of renal action of xipamide.
Gold CH; Viljoen M
Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):522-7. PubMed ID: 436356
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological and toxicological properties of the saluretic xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide)].
Leuschner F; Neumann W; Bahrmann H
Arzneimittelforschung; 1975 Feb; 25(2):245-51. PubMed ID: 1173041
[TBL] [Abstract][Full Text] [Related]
18. [Dose-response relationship of xipamide in healthy subjects].
Knauf H; Haase W; Mutschler E
Arzneimittelforschung; 1980; 30(9):1599-607. PubMed ID: 7006620
[TBL] [Abstract][Full Text] [Related]
19. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].
Ando M
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568
[TBL] [Abstract][Full Text] [Related]
20. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
Schnackenberg CG; Merz E; Brooks DP
Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
